Viral Vector and Plasmid DNA Manufacturing Market is estimated to be US$ 2.35 billion by 2030 with a CAGR of 3.9% during the forecast period-By PMI Covina, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Viral Vectors and Plasmid DNA have become an important tool used for transferring genetic material into cells. Adenovirus, herpes simplex virus,...

The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15% till 2035, claims Roots Analysis London, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market, 2022-2035”...

The viral and non-viral vector manufacturing market is projected to grow at an annualized rate of over 15%, claims Roots Analysis London, May 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition) 2021 – 2030” report to its...